Adrienne Farid has sold IPSC and made no open-market buys since Mar 2024

Adrienne Farid is a biotech executive and drug developer who serves as Chief Development Officer at Century Therapeutics, Inc., a biotechnology company focused on allogeneic cell therapies for cancer and other diseases.( She has held multiple senior roles at Century Therapeutics, including Chief Operations Officer and Head of Early Development from April 2021 to October 2024, and earlier as Chief Development Officer starting in 2019.( In her capacity as a corporate insider, Farid has reported several stock transactions in Century Therapeutics, including multiple Form 4 filings that identify her as Chief Operations Officer of the company.(

Farid’s career prior to Century Therapeutics includes senior leadership positions in project leadership and business operations in research and early development at other biopharmaceutical organizations, reflecting extensive experience in advancing innovative therapies from early-stage development toward the clinic.( She holds a Ph.D. in Chemistry from Columbia University and a B.A. in Biochemistry from Barnard College, underscoring her strong scientific and technical foundation for her executive roles in drug development.(

Written by Perplexity from public sources.